WCM
MRVI icon

WealthTrak Capital Management’s Maravai LifeSciences MRVI Stock Holding History

WealthTrak Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-110
Closed -$244 – 1019
2025
Q1 		$244 Buy
+110
New +$435 ﹤0.01% 815

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WealthTrak Capital Management's MRVI Position: Q2 2025 in Review

WealthTrak Capital Management sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 110 shares — an estimated $244 sold.

WealthTrak Capital Management first reported a position in MRVI in Q1 2025 and held it in 1 quarter. The position peaked at $244 in Q1 2025. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • WealthTrak Capital Management reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 110 Maravai LifeSciences shares in Q2 2025, an estimated $244.
  • WealthTrak Capital Management first reported a position in Maravai LifeSciences in Q1 2025 and held it in 1 quarter.
  • WealthTrak Capital Management's Maravai LifeSciences position peaked at $244 in Q1 2025.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on WealthTrak Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.